Post by Protara Therapeutics

Have you seen our new THRIVE-3 clinical study website? Our THRIVE-3 Phase 2b/3 study is designed to assess the efficacy and safety of low and high dose intravenous #Choline Chloride in adolescent and adult patients receiving long-term parenteral nutrition (PN). We are actively recruiting for this study and are pleased to launch this website with study information and patient resources. Learn more: www.thrive3study.com #RareDisease #Choline #ClinicalNutrition #ParenteralSupport #CholineDeficiency #ClinicalTrials